Novel spiropyrrolidine heterocyclic hybrids were synthesized for the first time in a sustainable fashion employing a 1,3-dipolar cycloaddition strategy to form a new class of azomethine ylides generated from tyrosine and acenaphthenequinone. Following their synthesis and characterization, these heterocyclic hybrids were tested for their anticancer activities by incubation at different concentrations and durations with different cancer and non-cancer cell cultures, and the results indicated a potential therapeutic activity. Further analysis of cancer cell death revealed that it occurred through a caspase-related apoptotic pathway, specifically mediated by caspase-3. These results demonstrated that the obtained spiropyrrolidine heterocyclic hybrids may be good hit compounds for the development of potential therapeutic agents for the treatment of malignant tumors.
Introduction
Hybrid multifunctional molecules carrying more than one pharmacophoric unit, wherein each individual active unit exerts diverse modes of action, can be useful in the treatment of complex, multifactorial diseases such as cancer.
1 Among various such compounds belonging to the nitrogen heterocycle class, spiropyrrolidine derivatives have attracted much interest as they constitute a central skeleton for a variety of alkaloids and pharmacologically active compounds. [2] [3] [4] In particular, highly substituted pyrrolidines are common structures in natural products and are also prevalent in a variety of biologically active compounds, 5, 6 including compounds potentially useful for the treatment of diseases such as diabetes, 7 cancer 8 and viral infections.
9,10
On the other hand, acenaphthenequinone derivatives have strong antioxidant properties and free radical scavenging activity that explains their ability to reduce lipid peroxidation [11] [12] [13] [14] The word "cancer" designs a potentially lethal group of diseases characterized by unregulated proliferation and a deregulation of apoptotic mechanisms. Apoptosis, an orchestrated event in which cells are programmed to die in response to specic stimuli, is crucial for sustaining the physiological balance between cell growth and cell death. 15 Apoptosis can be caused by two major pathways: the extrinsic pathway, that involves the binding of "death ligands" to "death receptors", and the intrinsic mitochondrial pathway, 16 initiated by cytotoxicity. Both pathways are regulated by a group of proteases known as caspases. 17 Targeting these pathways by chemotherapeutic drugs is a proven therapeutic strategy to control tumor growth and cancer progression. 18 The side effects associated to the use of current chemotherapeutic agents and the development of resistance are major obstacles to treat cancer effectively. [19] [20] [21] Thus, it is necessary to identify and develop new anti-cancer drug candidates with improved efficacy and reduced side effects to complement the present chemotherapeutic strategies.
The transcription factor p53 has been described as the "guardian of the human genome" and controls the cellular response to stress through the induction of apoptosis, among other processes. One of the mechanisms that regulate the levels of p53 is based on its interaction with mdm2, an ubiquitin ligase that targets p53 for degradation by the proteasome. Antagonists of the p53/mdm2 interaction are potentially very interesting as potential anticancer agents, although small molecules showing this activity are scarce. Among them, we will mention some synthetic spiropyrrolidine derivatives including MI-219, MI-773 and M-888. The low stability in solution of these compounds 22 prompted us to attempt the generation of related, more stable compounds, and in this connection we have recently reported the synthesis of compounds I (Fig. 1) , which caused apoptotic cell death but unfortunately displayed only moderate anticancer activity. 23 In an effort to improve the activity of these compounds, we decided to investigate the replacement of the oxindole moiety by acenaphthene (compounds II).
The diversity of the biological functions of pyrrolidines has stimulated efforts for the expedient and controlled synthesis of this class of compounds.
24,25 1,3-Dipolar cycloaddition reactions provides a direct and straightforward entry for the construction of pyrrolidine heterocyclic units in a highly regio-and stereoselective manner. [26] [27] [28] [29] [30] In particular, the cycloaddition of nonstabilized azomethine ylides with olens represents one of the most convergent approaches for the construction of ve-membered hybrid heterocycles. [31] [32] [33] These strategies permit the construction of complex molecules from the easily available starting materials in a single synthetic step. In view of their great synthetic potential, this cycloaddition reaction is a subject of intensive research in organic synthesis.
34-36
The interesting properties of the above-mentioned structural motifs, in conjunction with our continued interest in the synthesis and/or biological activities of novel heterocyclic hybrids, [37] [38] [39] [40] [41] [42] [43] prompted us to investigate the cycloaddition reactions of b-nitrostyrenes and non-stabilized azomethine ylides derived from acenaphthenequinone and tyrosine, a combination that has not been employed previously for the in situ generation of azomethine ylides. Tyrosine, in particular, has not, to our knowledge, been employed for the generation of azomethine ylides.
Our synthetic strategy for the formation of functionalized novel pyrrolidine analogues is summarized in Scheme 1. Furthermore, the synthesized analogues were tested for their therapeutic efficacy by means of in vitro cell culture systems, where the compounds were assayed for their effect of toxicity onto different cancer and non-cancer cell lines. The viability and proliferation of the cultured cells were measured followed by the in depth analysis of cell death mechanism.
Results and discussion

Chemistry
The synthetic approach was based on a three-component strategy involving the 1,3-dipolar cycloaddition reaction between b-nitrostyrenes 1(a-f) and azomethine ylide generated in situ from acenaphthenequinone 2 and tyrosine 3 as outlined in Scheme 2. The synthesis of required b-nitrostyrenes was performed following the previously reported procedure. 44 The cycloaddition reactions were effected by reuxing equimolar amounts of the reactants 1, 2 and 3 in methanol, and the products obtained were puried by column chromatography using hexane and ethyl acetate as eluent. This reaction proceeded in a highly regio-and stereocontrolled fashion, as only one diastereoisomer of the cycloadduct 4(a-f) was formed in excellent yields (90-95%) despite the presence of four stereocenters. The spiropyrrolidine was obtained through a process which involved the formation of three C-C bonds and four contiguous stereocenters, one of which is quaternary.
A careful structural elucidation of the pyrrolidine 4 was accomplished with the help of FT-IR, NMR spectroscopy and mass spectrometric data as discussed for a representative example 4f (ESI of Fig. S1-S8 † .48 and 37.11 ppm is assigned to C-3, C-4, C-5 and C-6 (benzylic carbon) respectively. The structure of other pyrrolidine derivatives 4(a-e) were also assigned similarly and were in good agreement with their NMR spectroscopic data. The selected 1 H and 13 C chemical shis of 4f is shown in Fig. 2 . A plausible mechanism for the regio-and stereoselective construction of spiropyrrolidine heterocyclic hybrids 4(a-f) is proposed in Scheme 3. The rationale for the regioselectivity observed is explicable on the basis that the transition state (TS 1 ) leading to 4 is likely to be more stable than the other possible one (TS 2 ), which would be destabilized by interactions between the aryl ring from the styrene derivative and the amino acid chain. The observed stereoselectivity is also explicable based on the fact that with the aryl ring attached to the pyrrolidine ring adjacent to the spiro carbon being cis to the carbonyl of the acenaphthenequinone moiety and trans to the nitro group. This stereoselectivity suggests that the transition state TS 3 leading to the unobserved stereoisomers suffers from unfavourable interactions between the phenyl ring and the acenaphthlene group of the acenaphthenequinone moiety (Scheme 3). The selectivity observed is also supported by our earlier reports. 
Biology
The MTT assay dependent cell viability studies following the treatment of testing samples, 4(a-f) with varying concentrations (5, 25, 50, 75 and 100 mM) and time periods (24 and 48 h) on different cell types: non-cancer (PCS-130-010 and BRL-3A) and cancer cell lines (A549 and Jurkat cell types) are compared and are shown in Fig. 3 and 4 respectively. It can be observed from Fig. 3 that all the tested compounds up to 100 mM concentration onto the two non-cancer cell types of PCS-130-010 and BRL-3A are exhibiting no signicant losses to the viability, revealing that the compounds are not toxic to the healthy-normal cells. This can be possibly due to the fact the healthy-normal cells in general possess resistance against xenobiotic impact until certain concentration levels, since oxidative stress or any other toxic mechanisms generated by the xenobiotics are easily nullied by the intracellular proteins having antioxidative properties. 47 However, from Fig. 4 , it can be observed that all compounds exhibit some level of toxicity to both cancer cell types as indicated by a reduction in the viability of cells treated with the compounds as compared with the cells without any treatment. We also observed from the results that the reduction of viability is getting increased upon an increase in sample concentration and incubation time. The most active compound was 4b while the least effective compound being the 4e as compared against the positive control of the anticancer drug camptothecin (CPT) (30 mM). The highest activity corresponded to 4b, with Br as a substituent, followed by Cl, H, CH 3 , CH 3 O and nitro derivatives. The two more active compounds were those with a higher lipophilicity (see the clog P values in ESI †), suggesting that cell penetration is of critical importance for activity. From the results, we calculated the IC 50 values for the tested samples using both cancer cell lines and the values are shown in Table 1 . In addition to the MTT assay-dependent absorption assay, the physical appearance and cell growth status for the Jurkat cells treated compounds over a 24 h and 48 h period were visualized by optical microscopy and are shown in the ESI of Fig. S19 and S20 † respectively. From the Scheme 2 Synthesis of highly functionalized pyrrolidines 4(a-f). gure, it can be observed that the healthy normal cells without any treatment are linked with each other while those treated with the positive control of CPT and our compounds are isolated due to loss of neighboring cells, and this gap increases upon increase of incubation time to 48 h. Cells undergoing apoptosis are generally characterized by distorted cell membrane architectures that allow the externalization/translocation of phosphatidylserine from the cytosol outward into the plasma membrane. 47 Phosphatidylserine is the basic component of the phospholipid bilayer that helps to maintain the shape and control selective permeability across the cell membrane 48 and is found outside the cell plasma membrane only when the cell membrane architecture gets compromised. Thus, phosphatidylserine is oen used as a marker for the detection of early apoptotic cells owing to its strong binding affinity to uorescence emitting calciumdependent phospholipid-binding proteins (Annexin V).
49,50
Simultaneous staining using AnnexinV-FITC and PI is included for the dye exclusion to differentiate between cells undergoing apoptosis (AnnexinV-FITC +ve PI Àve ) and necrosis (AnnexinV-FITC +ve PI +ve ). 51, 52 In this study, Annexin V-FITC assay was employed to differentiate the cells undergoing early and late apoptosis, following the treatment with the positive control (CPT) and 4a respectively in Fig. 5 (for a 24 h period) . As shown in gure, 95% of the cells in the untreated groups are viable ( Fig. 5A-1, upper le) . However, for the groups treated with CPT, the number of viable cells were drastically reduced to 16% (Fig. 5B-1 , lower le) and about 58% cells migrated into early stage apoptosis (Fig. 5B-1 , upper right) and 14% into late apoptosis ( Fig. 5B-1, lower right) ; the results further showed some of the cells (about 10%) becoming necrotic ( Fig. 5B-1 , upper le). Similarly, in the case of 4a treated groups, 53% of the cells remain viable (Fig. 5C-1 , lower le), with almost 13% (Fig. 5C-1 , lower right) in early stage of apoptosis and 27% ( Fig. 5C-1 , upper right) in late stage of apoptosis. From the results, it is obvious that the toxicity of CPT was greatly reduced in its combination form as 4a, owing to the fact that about 52% of the cells treated with 4a remain viable compared to the 16% cell viability for CPT treated groups. Similarly, for this group, compound 4a was able to regulate/inhibit the progression of the cells going into necrosis (6%) compared to 10% for the groups treated with CPT. Furthermore, the corresponding uorescence intensities for the Annexin-V-FITC treated cells, i.e. untreated, CPT and 4a treated samples are shown in Fig. 5 of A-2, B-2, and C-2 respectively. From each section of gure, M1 corresponds to the uorescence intensity from the live cells while the M2 represents the uorescence from the nearly dying apoptotic cells. Hence from this analysis, it is clearly evident that 4a treated cells have the highest number (>89%) of apoptotic dying cells as compared with the CPT treated cells (68%) and cells without treatment (4%). The observation of similar ndings even for the 48 h period sample incubated systems (ESI of During the onset of apoptosis, complementary cascades were also observed to be activated; initiating caspase activation and inducing apoptotic cell execution. 53, 54 The activation of these cascades implies either the occurrence of intrinsic mitochondria-mediated apoptotic pathway triggered by ionizing radiation or cytotoxic metabolites or extrinsic apoptotic pathway, which is receptor-mediated. 55 Specically, caspase-3 and -9, terminal factor of apoptosis, exists as an inactive precursor in the cytoplasm, which is activated during the apoptosis and takes part in apoptosis induced by multiple factors.
56 Caspase-3 is activated by the upstream caspase-8 and caspase-9, and since it serves as a convergence point for different signaling pathways, it is widely used as a monitordevice in an apoptosis assay. We explored the use of the active form of caspase-3 for the detection of apoptotic events. This protease has been implicated as an "effector" caspase associated with the initiation of the "death cascade" and is therefore an important marker to detect the onset/transformation cells into the apoptotic signaling pathway. 57 The representative ow cytometric data of caspase-3 activity in cells treated with the CPT and 4a and that of the normal control over a 24 h period is shown in Fig. 6 . The ow cytometric data for the untreated, CPT and 4a treated samples are shown in Fig. 6 of A-1, B-1 , and C-1 respectively. Also, the uorescence intensity data presented in the gure, the treatment of the cells with CPT showed an increase (>54%) in active caspase-3 expression (Fig. 6B-2 ) compared to the untreated cells (1.22% in Fig. 6A-2) . Similarly, there was an increase in active caspase-3 staining (Fig. 6C-2) by >85% following the treatment with the test compound (4a) as compared against the negative control ( Fig. 6A-2 ) and positive control ( Fig. 6B-2) . The treatment with 4a demonstrated an increase in active caspase-3 expression as compared to the CPT groups. The results revealed that the overexpression of caspase-3 improved the apoptosis of cells treated by CPT and 4a, meanwhile, the 4a in a more aggressive way strengthened the pro-apoptotic ability of caspase-3. In addition, the increased incubation period to a 48 h for the same samples shown in the ESI of Fig. S12 † also revealing the similar information and from the analysis, these ndings demonstrated that compound 4a played a synergistic role towards the induction of apoptosis in the cell lines.
Conclusion
An efficient synthesis of novel highly functionalized pyrrolidine derivatives has been achieved in excellent yields via a one pot three component 1,3-dipolar cycloaddition reaction of b-nitrostyrenes and non-stabilized azomethine ylides generated in situ from acenaphthenequinone and tyrosine. In addition to the synthesis protocol, the in vitro cytotoxicity assays shown that all the synthesized compounds have good therapeutic efficacy against both the cancer cell lines. However, this in vitro cytotoxic effect seems to be signicantly affected by the substituent type, i.e. the halogen containing derivatives proved to be highly active as against the other derivatives. Further, the cell death in both the cancer cell lines indicated to be apoptotic way mediated by an increased activation of caspase-3 proteins. The highly functionalized pyrrolidine derivatives obtained in the present study can be employed for the sustainable treatment of cancerous tumors while simultaneously protecting the noncancer cells during the cancer chemotherapy which in most cases is associated with many side effects. Furthermore, the presence of multiple functional groups in these hybrid heterocycles, enriches the budding for further alteration of these compounds into therapeutically useful candidates.
Materials and methods
Chemistry
All nitrostyrenes were prepared according to literature procedure 44 and all other reagents and solvents were purchased from commercial suppliers and used without further purication. Reactions were monitored by thin-layer chromatography (TLC) on silica gel. Column chromatography was done on silica gel (230-400 mesh) using hexane-ethyl acetate as eluent. Melting points were recorded using open capillary tubes and are uncorrected. The 1 H, 13 C and 2-D NMR spectra were recorded on a Jeol 500 MHz instruments in CDCl 3 using TMS as internal standard. Standard Jeol soware was used throughout. Chemical shis are given in parts per million (d-scale) and the coupling constants are given in Hertz. IR spectra were recorded seeded in a 6-well plate. Aer overnight growth, the cells were treated with 4a compound at IC 50 concentration as determined from the cell viability assay. Following the trypsinization, the cells were centrifuged at 1000 Â g for 10 min, and the pellet was gently re-suspended in 100 mL AnnexinV-FITC binding buffer and then incubated with 5 mL of AnnexinV-FITC in the dark for 10 min at 25 C. The cells were then centrifuged at 2000 rpm for 5 min, gently re-suspended in 500 mL of AnnexinV-FITC binding buffer and 5 mL of PI was added in an ice bath, followed by ow cytometry analysis. From the result, the apoptotic cells were analyzed using the Cell Quest soware. 4.2.5. Cell cycle analysis. Jurkat cells were plated at 1 Â 10 6 cells per well in a six-well plate for 12 h and then cells were exposed with compound 4a at IC 50 concentrations in serum-free media and incubated for an additional 24 or 48 h periods. Following the trypsinization, the cells were centrifuged at 1000 Â g for 10 min, and the pellet was re-suspended in PBS. Fixation was completed by adding 70% cold ethanol for at least 2 h. The xed cells were centrifuged at 1000g for 10 min, and the pellet suspended in PBS. Aer 60 s, the cells were centrifuged as before, and the pellet re-suspended in 1 mL of PI staining solution. Immediately aer 15 min of incubation, the cells were analyzed to determine the cell cycle stage using ow cytometry with an excitation wavelength of 488 nm and an emission at 670 nm using the Cell Quest soware. The data presented is of at least three independent experiments conducted in triplicates. with PBS and treated with 20 mL of caspase-3 FITC followed by incubation for 60 min at room temperature in dark. The cells were washed with PBS and re-suspended in 0.5 mL of PBS and then analyzed for caspase-3 expression using BD FACS Calibur. 4.2.7. Statistical analysis. All the in vitro molecular biology experimental results presented are the mean AE SD of at least three replicate analyses. For the results, the performed statistical analysis was based on student's t-test with the signicant value set at p < 0.05 (represented by *) and highly signicant value set at p < 0.01 (represented by **) against the control ran with the aid of Graphpad prism soware (version 6). 
Experimental
6.97 (d, 2H, J ¼ 7.5 Hz, ArH), 7.14 (d, 2H, J ¼ 8.0 Hz, ArH), 7.54 (d, 1H, J ¼ 8.0 Hz, ArH), 7.60 (d, 1H, J ¼ 7.0 Hz, ArH), 7.75-7.
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